TipRanks
Drug Free Solution Inc (DSOL)
OTHER OTC:DSOL
US Market

Drug Free Solution (DSOL) Ratios

9 Followers

Drug Free Solution Ratios

See a summary of DSOL’s cash flow.
Ratios
May 20May 19
Liquidity Ratios
Current Ratio
― 0.04
Quick Ratio
― 0.04
Cash Ratio
― 0.04
Solvency Ratio
― -4.19
Operating Cash Flow Ratio
― -1.15
Short-Term Operating Cash Flow Coverage
― 0.00
Net Current Asset Value
$ ―$ -320.80K
Leverage Ratios
Debt-to-Assets Ratio
― 0.00
Debt-to-Equity Ratio
― 0.00
Debt-to-Capital Ratio
― 0.00
Long-Term Debt-to-Capital Ratio
― 0.00
Financial Leverage Ratio
― -0.19
Debt Service Coverage Ratio
― 0.00
Interest Coverage Ratio
― 0.00
Debt to Market Cap
― 0.00
Interest Debt Per Share
― 0.00
Net Debt to EBITDA
― <0.01
Profitability Margins
Gross Profit Margin
―100.00%
EBIT Margin
―-174816.77%
EBITDA Margin
―-173282.86%
Operating Profit Margin
―-174817.39%
Pretax Profit Margin
―-174816.77%
Net Profit Margin
―-174816.77%
Continuous Operations Profit Margin
―-174816.77%
Net Income Per EBT
―100.00%
EBT Per EBIT
―100.00%
Return on Assets (ROA)
―-2680.17%
Return on Equity (ROE)
―501.18%
Return on Capital Employed (ROCE)
―501.18%
Return on Invested Capital (ROIC)
―501.18%
Return on Tangible Assets
―-11256.40%
Earnings Yield
―-1.22%
Efficiency Ratios
Receivables Turnover
― 0.00
Payables Turnover
― 0.00
Inventory Turnover
― 0.00
Fixed Asset Turnover
― 0.00
Asset Turnover
― 0.02
Working Capital Turnover Ratio
― >-0.01
Cash Conversion Cycle
― 0.00
Days of Sales Outstanding
― 0.00
Days of Inventory Outstanding
― 0.00
Days of Payables Outstanding
― 0.00
Operating Cycle
― 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
― >-0.01
Free Cash Flow Per Share
― >-0.01
CapEx Per Share
― <0.01
Free Cash Flow to Operating Cash Flow
― 1.10
Dividend Paid and CapEx Coverage Ratio
― -10.40
Capital Expenditure Coverage Ratio
― -10.40
Operating Cash Flow Coverage Ratio
― 0.00
Operating Cash Flow to Sales Ratio
― -475.65
Free Cash Flow Yield
―-0.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
― -82.05
Price-to-Sales (P/S) Ratio
― 143.43K
Price-to-Book (P/B) Ratio
― -411.20
Price-to-Free Cash Flow (P/FCF) Ratio
― -275.08
Price-to-Operating Cash Flow Ratio
― -301.54
Price-to-Earnings Growth (PEG) Ratio
― 1.86
Price-to-Fair Value
― -411.20
Enterprise Value Multiple
― -82.76
Enterprise Value
― 115.45M
EV to EBITDA
― -82.76
EV to Sales
― 143.41K
EV to Free Cash Flow
― -275.05
EV to Operating Cash Flow
― -301.51
Tangible Book Value Per Share
― >-0.01
Shareholders’ Equity Per Share
― >-0.01
Tax and Other Ratios
Effective Tax Rate
― 0.00
Revenue Per Share
― <0.01
Net Income Per Share
― >-0.01
Tax Burden
― 1.00
Interest Burden
― 1.00
Research & Development to Revenue
― 0.00
SG&A to Revenue
― 0.00
Stock-Based Compensation to Revenue
― 0.00
Income Quality
― 0.27
Currency in USD